Forte Biosciences, Inc.
Healthcare · EUR · F
Price
€18.531
Cap
€491.90M
Earnings
—
30d Trend
-33.1%
93% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 51×Macro 0.99 (−1%)=50
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Medium-term outlook is neutral — no clear directional thesis
BRAIN47'S ASSESSMENT
I rate Forte Biosciences, Inc. at 50/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is momentum at 77/100. I classify this as a speculative position with the strongest thesis on a medium-term horizon.
PAST PERFORMANCE
1 MONTH
-21.3%
3 MONTHS
-31.3%
12 MONTHS
+114.8%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Medium-term outlook is neutral — no clear directional thesis. Momentum (77) and Quality (50) are the primary strengths. I note that fundamentals is the weakest area at 15/100 — this warrants monitoring. Historical volatility is elevated at 93%. I classify this as a speculative position — elevated volatility at 93% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.